BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 31454181)

  • 1. TERT rs10069690 polymorphism and cancers risk: A meta-analysis.
    He G; Song T; Zhang Y; Chen X; Xiong W; Chen H; Sun C; Zhao C; Chen Y; Wu H
    Mol Genet Genomic Med; 2019 Oct; 7(10):e00903. PubMed ID: 31454181
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between the TERT Genetic Polymorphism rs2853676 and Cancer Risk: Meta-Analysis of 76,108 Cases and 134,215 Controls.
    Cao JL; Yuan P; Abuduwufuer A; Lv W; Yang YH; Hu J
    PLoS One; 2015; 10(6):e0128829. PubMed ID: 26042809
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The TERT rs2736100 polymorphism and cancer risk: a meta-analysis based on 25 case-control studies.
    Zou P; Gu A; Ji G; Zhao L; Zhao P; Lu A
    BMC Cancer; 2012 Jan; 12():7. PubMed ID: 22221621
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of the Telomerase Reverse Transcriptase rs10069690 Polymorphism with the Risk, Age at Onset and Prognosis of Triple Negative Breast Cancer.
    Zins K; Peka E; Miedl H; Ecker S; Abraham D; Schreiber M
    Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768147
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polymorphisms in the telomerase reverse transcriptase promoter are associated with risk of breast cancer: A meta-analysis.
    Li ZY; Dong YL; Feng Y; Zhang Z; Cao XZ
    J Cancer Res Ther; 2016; 12(2):1040-4. PubMed ID: 27461695
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The TERT MNS16A polymorphism contributes to cancer susceptibility: meta-analysis of the current studies.
    Chen P; Zou P; Yan Q; Xu H; Zhao P; Gu A
    Gene; 2013 May; 519(2):266-70. PubMed ID: 23462332
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MNS16A polymorphism of the
    Yuan H; Han Z; Teng Z; Wang Y; Li J; Chang X; Zhang Y
    Nucleosides Nucleotides Nucleic Acids; 2023; 42(12):1004-1018. PubMed ID: 37345793
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between TERT rs2853669 polymorphism and cancer risk: A meta-analysis of 9,157 cases and 11,073 controls.
    Liu Z; Wang T; Wu Z; Zhang K; Li W; Yang J; Chen C; Chen L; Xing J
    PLoS One; 2018; 13(3):e0191560. PubMed ID: 29534075
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Telomerase reverse transcriptase locus polymorphisms and cancer risk: a field synopsis and meta-analysis.
    Mocellin S; Verdi D; Pooley KA; Landi MT; Egan KM; Baird DM; Prescott J; De Vivo I; Nitti D
    J Natl Cancer Inst; 2012 Jun; 104(11):840-54. PubMed ID: 22523397
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The TERT rs2736100 polymorphism increases cancer risk: A meta-analysis.
    Li H; Xu Y; Mei H; Peng L; Li X; Tang J
    Oncotarget; 2017 Jun; 8(24):38693-38705. PubMed ID: 28418878
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The
    Hong T; Luo M; Liu Q
    Genet Test Mol Biomarkers; 2020 Apr; 24(4):181-187. PubMed ID: 32202925
    [No Abstract]   [Full Text] [Related]  

  • 12. Increased lung cancer risk associated with the TERT rs2736100 polymorphism: an updated meta-analysis.
    Yang J; Jiao S
    Tumour Biol; 2014 Jun; 35(6):5763-9. PubMed ID: 24590268
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of TERT rs2736098 polymorphism with cancer risk: a meta-analysis.
    Zhang XJ; Xu Z; Gong YL; Tang CJ; Chen JF
    Asian Pac J Cancer Prev; 2012; 13(10):4943-6. PubMed ID: 23244087
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Telomerase reverse transcriptase (TERT) rs2736100 polymorphism contributes to increased risk of glioma: evidence from a meta-analysis.
    Peng Z; Tian D; Chen Q; Zhang S; Liu B; Ji B
    Int J Clin Exp Med; 2015; 8(1):422-30. PubMed ID: 25785013
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Associations of telomerase reverse transcriptase rs10069690 and rs2736100 polymorphisms with papillary thyroid carcinoma.
    Liu Y; Shi F
    Eur J Cancer Prev; 2020 May; 29(3):259-265. PubMed ID: 31651569
    [TBL] [Abstract][Full Text] [Related]  

  • 16. hTERT gene polymorphism correlates with the risk and the prognosis of thyroid cancer.
    Gong L; Xu Y; Hu YQ; Ding QJ; Yi CH; Huang W; Zhou M
    Cancer Biomark; 2016 Jul; 17(2):195-204. PubMed ID: 27472887
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human TERT promoter polymorphism rs2853669 is associated with cancers: an updated meta-analysis.
    Aziz MA; Jafrin S; Islam MS
    Hum Cell; 2021 Jul; 34(4):1066-1081. PubMed ID: 33743166
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TERT Gene rs2736100 and rs2736098 Polymorphisms are Associated with Increased Cancer Risk: A Meta-Analysis.
    Zhang X; Chen Y; Yan D; Han J; Zhu L
    Biochem Genet; 2022 Feb; 60(1):241-266. PubMed ID: 34181135
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between the rs2736100 polymorphisms of telomerase reverse transcriptase gene and digestive cancers: A meta-analysis.
    Song H; Han M; Li K; Zhao Y; Xu C; Lei X
    J Cancer Res Ther; 2021 Nov; 17(5):1202-1208. PubMed ID: 34850768
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between HIF-1α C1772T/G1790A polymorphisms and cancer susceptibility: an updated systematic review and meta-analysis based on 40 case-control studies.
    Yan Q; Chen P; Wang S; Liu N; Zhao P; Gu A
    BMC Cancer; 2014 Dec; 14():950. PubMed ID: 25496056
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.